What's new in PAH in 2024

10/01/24 • 34 min

Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Send us a text

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

Instagram @pulmapps
Twitter@pulmapp
Facebook @association of pulmonary advance practice providers.

Send us a text

Instagram @pulmapps
Twitter@pulmapp
Facebook @association of pulmonary advance practice providers.

Previous Episode

Is this SOB my problem or yours?: Referral to Cardiology

In this podcast episode, we interview Brian Rose, a cardiovascular physician assistant, about the intersection of cardiology and pulmonology in managing patients with breathlessness. We discuss the evaluation and management of dyspnea on exertion, the role of diastolic dysfunction and valvular disease in causing pulmonary hypertension, and the importance of collaboration between cardiology and pulmonology.

Send us a text

Instagram @pulmapps
Twitter@pulmapp
Facebook @association of pulmonary advance practice providers.

Next Episode

PFT 101

In this episode, we interview Erin Klein Carlson, a respiratory therapist, about the basics of pulmonary function testing. We discuss the reasons for ordering a pulmonary function test, the types of patients that may not be suitable for testing, and the different types of lung function tests available. We also explore the interpretation of flow loops and the importance of z-scores, race and how to approach transgender patients and the challenges of interpreting lung function in this population.

Send us a text